Impact of Platelet-Rich Fibrin Combined with Silver Nanoparticle Dressing on Healing Time and Therapeutic Efficacy of Chronic Refractory Wounds.

Introduction: Objective • This study aimed to investigate the clinical value of combining platelet-rich fibrin (PRF) with nano silver (AgNP) dressing in the treatment of chronic refractory wounds. Introduction: Methods • A total of 120 patients with chronic refractory wounds were selected from our hospital between January 2020 and January 2022. The patients were randomly divided into the control group and the study group, with 60 cases in each group. The control group received basic treatment combined with AgNP dressing, while the study group received PRF combined with AgNP dressing. A comparison was made between the two groups in terms of wound healing time, hS-CRP levels, VISUAL analogue scale (VAS) scores, procalcitonin (PCT) levels, clinical efficacy, and complications. Introduction: Results • Before treatment, there were no significant differences in hS-CRP, VAS, and PCT levels between the two groups (P > .05). However, after treatment, the study group showed significantly lower hS-CRP, VAS, and PCT levels compared to the control group (P < .05). The study group also exhibited a shorter wound healing time, a higher rate of excellent and good curative effect (95.00% vs 81.67%) compared to the control group (χ2 = 5.175, P < .05), and a lower incidence of wound complications (6.67% vs 21.67%) compared to the control group (χ2 = 4.386, P < .05). Introduction: Conclusions • The combination of PRF and AgNP dressing can effectively alleviate pain and local inflammation in patients with chronic refractory wounds, improve the wound healing rate, shorten the healing time, and reduce the risk of complications such as infection spread.

The Value of Continuous Closed Negative Pressure Drainage Combined with Antibacterial Biofilm Dressing in Postoperative Wound Healing for Severe Pancreatitis.

Objective: To investigate the application value of continuous vacuum sealing drainage (VSD) combined with antibacterial biofilm hydraulic fiber dressing in wound healing after surgery for severe acute pancreatitis (SAP). Methods: A total of 82 SAP patients who underwent minimally invasive surgery in our hospital from March 2021 to September 2022 were randomly divided into two groups using a random number table method. Each group consisted of 41 cases. Both groups received surgical treatment, with the control group receiving VSD treatment and the observation group receiving VSD treatment combined with antibacterial biofilm hydraulic fiber dressing. The postoperative recovery efficiency, preoperative and postoperative wound area reduction rate, pressure ulcer healing score (PUSH), serum biological indicators (white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT)), and the rate of wound-related adverse reactions were compared between the two groups. Results: There was no statistical difference between the two groups in the time to resume eating (P > .05). However, the wound healing time and hospitalization days in the observation group were significantly shorter than those in the control group (P < .05). After 7 and 14 days of treatment, the wound area reduction rate in the observation group was significantly higher than in the control group, and the PUSH score was significantly lower than in the control group (P < .05). WBC, CRP, and PCT levels in the observation group were lower than in the control group (P < .05). The incidence of wound-related adverse reactions in the observation group (12.20%) was significantly lower than that in the control group (34.15%) (P < .05). Conclusions: The application of VSD combined with antibacterial biofilm hydraulic fiber dressing in the postoperative wound healing of SAP has a significant effect. It improves wound healing efficiency, reduces pressure ulcer scores, decreases inflammation indicators, and lowers the incidence of adverse reactions. While further research is needed to determine its impact on infection and inflammation prevention, this treatment approach shows promise for clinical application.